Name | N-(2-Aminophenyl)-4-[(4-methylene-1-oxo-3,4-dihydro-2(1H)-isoquinolinyl)methyl]benzamide |
---|---|
Synonyms |
Benzamide, N-(2-aminophenyl)-4-[(3,4-dihydro-4-methylene-1-oxo-2(1H)-isoquinolinyl)methyl]-
N-(2-Aminophenyl)-4-[(4-methylene-1-oxo-3,4-dihydro-2(1H)-isoquinolinyl)methyl]benzamide MFCD30182338 |
Description | MI-192 is a selective HDAC2 and HDAC3 inhibitor with IC50s of 30 nM and 16 nM, respectively. MI-192 is more selective for HDAC2/3 than other HDAC isomers.MI-192 induces myeloid leukaemic cells apoptosis. Anticaner and neuroprotective activities[1][2]. |
---|---|
Related Catalog | |
In Vitro | MI-192 (0.15-1 μM; 72 h) induces differentiation and is cytotoxic through promotion of apoptosis in acute myeloid leukaemic cell lines U937, HL60 and Kasumi-1[1]. Apoptosis Analysis[1] Cell Line: HL60 and Kasumi-1 cells Concentration: 150 nM, 300 nM, 500 nM, 1 μM Incubation Time: 72 h Result: Induced a substantial degree of apoptosis in both HL60 and Kasumi-1 cells. |
In Vivo | MI-192 (40 mg/kg; i.p; once a day; for 3 days) shows the neuroprotective activity in the mouse brain subjected to photothrombotic stroke[2]. Animal Model: Adult male outbred mice CD-1 (20-25 g) with photothrombotic stroke (PTS)[2] Dosage: 40 mg/kg Administration: i.p; once a day; for 3 days Result: Reduced the volume of the PTS-induced infarction core in the mouse brain, partly restored the functional symmetry in the forelimb use, decreased the level of PTS-induced apoptosis and acetylation of α-tubulin characteristic for stable microtubules, and increased the expression of GAP-43 in the cerebral cortex of the damaged hemisphere. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 565.0±50.0 °C at 760 mmHg |
Molecular Formula | C24H21N3O2 |
Molecular Weight | 383.44 |
Flash Point | 295.5±30.1 °C |
Exact Mass | 383.163391 |
LogP | 2.19 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.693 |
Storage condition | 2-8°C |